These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 12661058)
1. Effects of annealing lyophilized and spray-lyophilized formulations of recombinant human interferon-gamma. Webb SD; Cleland JL; Carpenter JF; Randolph TW J Pharm Sci; 2003 Apr; 92(4):715-29. PubMed ID: 12661058 [TBL] [Abstract][Full Text] [Related]
2. Surface adsorption of recombinant human interferon-gamma in lyophilized and spray-lyophilized formulations. Webb SD; Golledge SL; Cleland JL; Carpenter JF; Randolph TW J Pharm Sci; 2002 Jun; 91(6):1474-87. PubMed ID: 12115847 [TBL] [Abstract][Full Text] [Related]
3. A new mechanism for decreasing aggregation of recombinant human interferon-gamma by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20. Webb SD; Cleland JL; Carpenter JF; Randolph TW J Pharm Sci; 2002 Feb; 91(2):543-58. PubMed ID: 11835212 [TBL] [Abstract][Full Text] [Related]
4. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Cleland JL; Jones AJ Pharm Res; 1996 Oct; 13(10):1464-75. PubMed ID: 8899836 [TBL] [Abstract][Full Text] [Related]
5. Protein quantity on the air-solid interface determines degradation rates of human growth hormone in lyophilized samples. Xu Y; Grobelny P; Von Allmen A; Knudson K; Pikal M; Carpenter JF; Randolph TW J Pharm Sci; 2014 May; 103(5):1356-66. PubMed ID: 24623139 [TBL] [Abstract][Full Text] [Related]
6. Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine T(g)' in pharmaceutical lyophilization. Searles JA; Carpenter JF; Randolph TW J Pharm Sci; 2001 Jul; 90(7):872-87. PubMed ID: 11458336 [TBL] [Abstract][Full Text] [Related]
7. Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations. Awotwe-Otoo D; Agarabi C; Read EK; Lute S; Brorson KA; Khan MA Int J Pharm; 2015 Jul; 490(1-2):341-50. PubMed ID: 25835267 [TBL] [Abstract][Full Text] [Related]
9. Effects of buffer composition and processing conditions on aggregation of bovine IgG during freeze-drying. Sarciaux JM; Mansour S; Hageman MJ; Nail SL J Pharm Sci; 1999 Dec; 88(12):1354-61. PubMed ID: 10585234 [TBL] [Abstract][Full Text] [Related]
10. Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations. Roy S; Jung R; Kerwin BA; Randolph TW; Carpenter JF J Pharm Sci; 2005 Feb; 94(2):382-96. PubMed ID: 15614819 [TBL] [Abstract][Full Text] [Related]
11. Effect of cryoprotectants on freezing, lyophilization, and storage of lyophilized recombinant alpha 1-antitrypsin formulations. Vemuri S; Yu CD; Roosdorp N PDA J Pharm Sci Technol; 1994; 48(5):241-6. PubMed ID: 8000898 [TBL] [Abstract][Full Text] [Related]
12. Counteracting effects of thiocyanate and sucrose on chymotrypsinogen secondary structure and aggregation during freezing, drying, and rehydration. Allison SD; Dong A; Carpenter JF Biophys J; 1996 Oct; 71(4):2022-32. PubMed ID: 8889176 [TBL] [Abstract][Full Text] [Related]
13. Thiol-disulfide exchange in peptides derived from human growth hormone during lyophilization and storage in the solid state. Chandrasekhar S; Topp EM J Pharm Sci; 2015 Apr; 104(4):1291-302. PubMed ID: 25631887 [TBL] [Abstract][Full Text] [Related]
14. An integrated process analytical technology (PAT) approach to monitoring the effect of supercooling on lyophilization product and process parameters of model monoclonal antibody formulations. Awotwe Otoo D; Agarabi C; Khan MA J Pharm Sci; 2014 Jul; 103(7):2042-2052. PubMed ID: 24840395 [TBL] [Abstract][Full Text] [Related]
15. Storage stability of keratinocyte growth factor-2 in lyophilized formulations: effects of formulation physical properties and protein fraction at the solid-air interface. Devineni D; Gonschorek C; Cicerone MT; Xu Y; Carpenter JF; Randolph TW Eur J Pharm Biopharm; 2014 Oct; 88(2):332-41. PubMed ID: 24859390 [TBL] [Abstract][Full Text] [Related]
16. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11). Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002 [TBL] [Abstract][Full Text] [Related]
17. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations. Schüle S; Friess W; Bechtold-Peters K; Garidel P Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996 [TBL] [Abstract][Full Text] [Related]
18. Lyophilization-induced protein denaturation in phosphate buffer systems: monomeric and tetrameric beta-galactosidase. Pikal-Cleland KA; Carpenter JF J Pharm Sci; 2001 Sep; 90(9):1255-68. PubMed ID: 11745778 [TBL] [Abstract][Full Text] [Related]
19. Insights into the influence of the cooling profile on the reconstitution times of amorphous lyophilized protein formulations. Beech KE; Biddlecombe JG; van der Walle CF; Stevens LA; Rigby SP; Burley JC; Allen S Eur J Pharm Biopharm; 2015 Oct; 96():247-54. PubMed ID: 26253503 [TBL] [Abstract][Full Text] [Related]
20. The effect of benzyl alcohol on recombinant human interferon-gamma. Lam XM; Patapoff TW; Nguyen TH Pharm Res; 1997 Jun; 14(6):725-9. PubMed ID: 9210188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]